Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K
Eag1
KV10.1 inhibitors
cancer
hERG
molecular dynamics
pharmacophore
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Aug 2021
20 Aug 2021
Historique:
received:
03
08
2021
revised:
18
08
2021
accepted:
19
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
29
9
2021
Statut:
epublish
Résumé
The K
Identifiants
pubmed: 34445705
pii: ijms22168999
doi: 10.3390/ijms22168999
pmc: PMC8396485
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Ether-A-Go-Go Potassium Channels
0
KCNH1 protein, human
0
Ligands
0
Potassium Channel Blockers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : J1-9192, N1-0098, P1-0245
Références
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Cell Physiol Biochem. 2008;22(5-6):601-10
pubmed: 19088442
PLoS One. 2017 Dec 8;12(12):e0188811
pubmed: 29220359
Sci Rep. 2019 Nov 12;9(1):16586
pubmed: 31719645
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
J Med Chem. 2013 Dec 12;56(23):9427-40
pubmed: 24224763
J Comput Chem. 2014 Oct 15;35(27):1997-2004
pubmed: 25130509
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12461-6
pubmed: 12209010
Pflugers Arch. 2018 Jun;470(6):981-993
pubmed: 29549440
Curr Med Chem. 2012;19(5):675-82
pubmed: 22204340
Mol Inform. 2018 Jul;37(6-7):e1700142
pubmed: 29465167
Bioorg Med Chem Lett. 2003 May 19;13(10):1829-35
pubmed: 12729675
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
J Comput Chem. 2011 Jul 30;32(10):2319-27
pubmed: 21500218
Med Res Rev. 2021 May 4;:
pubmed: 33945158
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12329-33
pubmed: 11005845
J Chem Inf Model. 2005 Jan-Feb;45(1):160-9
pubmed: 15667141
FEBS Lett. 2006 Sep 18;580(21):5059-66
pubmed: 16949586
Cancers (Basel). 2020 Aug 25;12(9):
pubmed: 32854244
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
J Mol Biol. 2000 Sep 8;302(1):205-17
pubmed: 10964570
J Biol Chem. 2020 Mar 27;295(13):4114-4123
pubmed: 32047112
Med Res Rev. 2005 Mar;25(2):133-66
pubmed: 15389727
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
pubmed: 9895674
J Med Chem. 2012 Jul 26;55(14):6582-94
pubmed: 22716043
J Pharmacol Exp Ther. 2002 May;301(2):427-34
pubmed: 11961040
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
J Mol Biol. 2021 Aug 20;433(17):167002
pubmed: 33891905
Nature. 1992 Mar 5;356(6364):83-5
pubmed: 1538787
Mol Pharmacol. 2004 Aug;66(2):240-9
pubmed: 15266014
Nat Rev Cancer. 2014 Jan;14(1):39-48
pubmed: 24336491
FEBS Lett. 2002 Mar 13;514(2-3):204-8
pubmed: 11943152
J Comput Chem. 2009 Jul 30;30(10):1545-614
pubmed: 19444816
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Front Pharmacol. 2020 Apr 15;11:411
pubmed: 32351384
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3438-42
pubmed: 8159766
J Mol Biol. 1996 Nov 22;264(1):121-36
pubmed: 8950272
Mol Pharmacol. 2004 May;65(5):1120-9
pubmed: 15102940
EMBO J. 1994 Oct 3;13(19):4451-8
pubmed: 7925287
Br J Pharmacol. 2003 Jan;138(1):161-71
pubmed: 12522086
J Gen Physiol. 2004 Oct;124(4):301-17
pubmed: 15365094
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
Mol Pharmacol. 2006 Feb;69(2):509-19
pubmed: 16291873
Science. 2016 Aug 12;353(6300):664-9
pubmed: 27516594
Cancers (Basel). 2021 Mar 12;13(6):
pubmed: 33808994
Med Res Rev. 2018 Mar;38(2):525-555
pubmed: 28467598
Sci Rep. 2020 Oct 1;10(1):16262
pubmed: 33004839
J Med Chem. 2002 Aug 29;45(18):3844-53
pubmed: 12190308
Cell. 2017 Apr 20;169(3):422-430.e10
pubmed: 28431243
J Biol Chem. 2004 Mar 12;279(11):10120-7
pubmed: 14699101
Mol Pharmacol. 2003 May;63(5):1051-8
pubmed: 12695533
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
Protein Sci. 1993 Sep;2(9):1511-9
pubmed: 8401235
Sci Rep. 2016 Apr 12;6:24182
pubmed: 27067805